FAM174C: A Promising Drug Target and Biomarker for Multiple Chronic Diseases

Target Name: FAM174C

NCBI ID: G55009

FAM174C

FAM174C: A Promising Drug Target and Biomarker for Multiple Chronic Diseases

Abstract:

FAM174C, a protein known to interact with various drug targets, has been identified as a potential drug target and biomarker for several chronic diseases. This protein has been shown to play a crucial role in multiple cellular processes, including cell signaling, DNA replication, and apoptosis. Additionally, FAM174C has been linked to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Therefore, targeting FAM174C as a drug target or biomarker could have a significant impact on the treatment of these diseases.

Introduction:

FAM174C is a protein that has been shown to play a crucial role in multiple cellular processes. It is a member of the FAM174 family, which is known to interact with various protein tyrosine kinases, including S/T kinases, tyrosine phosphatases, and G protein-coupled receptors. FAM174C has been shown to regulate various cellular processes, including cell signaling, DNA replication, and apoptosis.

FAM174C has also been linked to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, studies have shown that high levels of FAM174C are associated with poor prognosis in patients with pancreatic cancer. Additionally, FAM174C has been shown to be overexpressed in various neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. Furthermore, FAM174C has been linked to autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

Drug Targeting FAM174C:

FAM174C has been identified as a potential drug target due to its unique structure and its involvement in multiple cellular processes. One of the main advantages of targeting FAM174C is its expressedness in various tissues and cells, including human tissues and diseases. Therefore, targeting FAM174C as a drug target could have a significant impact on the treatment of various diseases.

One potential mechanism by which FAM174C could be targeted as a drug is its role in cell signaling. FAM174C has been shown to play a role in several signaling pathways, including the PI3K/Akt signaling pathway, the TGF-β signaling pathway, and the NF-kappa-B signaling pathway. Therefore, inhibiting FAM174C activity could lead to a reduction in cellular signaling, which could have a negative impact on the treatment of various diseases.

Another potential mechanism by which FAM174C could be targeted as a drug is its role in DNA replication. FAM174C has been shown to play a role in the replication of DNA in various cell types, including human cells. Therefore, inhibiting FAM174C activity could lead to reduced DNA replication, which could have a negative impact on the treatment of various diseases.

FAM174C is also involved in apoptosis, which is a crucial process in cell signaling and development. Therefore, targeting FAM174C as a drug target could also have a negative impact on the treatment of various diseases.

Biomarker Analysis:

FAM174C has been shown to be involved in various cellular processes, including cell signaling, DNA replication, and apoptosis. Therefore, it could be a potential biomarker for various diseases. Studies have shown that FAM174C is expressed in various tissues and cells, including human tissues and diseases. Therefore, targeting FAM174C as a biomarker for various diseases could have a significant impact on the diagnosis and treatment of these diseases.

Targeted Therapies:

FAM174C has been identified as a potential drug target due to its unique structure and its involvement in multiple cellular processes. Targeting FAM174C as a drug target could have a significant impact on the treatment of various diseases.

One potential

Protein Name: Family With Sequence Similarity 174 Member C

The "FAM174C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM174C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets